371 related articles for article (PubMed ID: 29464276)
1. After the fall: improving osteoporosis treatment following hip fracture.
Kuiper BW; Graybill S; Tate JM; Kaufman N; Bersabe D
Osteoporos Int; 2018 Jun; 29(6):1295-1301. PubMed ID: 29464276
[TBL] [Abstract][Full Text] [Related]
2. Post-fracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012.
Cheung MY; Ho AW; Wong SH
Hong Kong Med J; 2018 Dec; 24(6):579-583. PubMed ID: 30449735
[TBL] [Abstract][Full Text] [Related]
3. Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures.
Liu Z; Li CW; Mao YF; Liu K; Liang BC; Wu LG; Shi XL
Orthop Surg; 2019 Jun; 11(3):380-385. PubMed ID: 31058448
[TBL] [Abstract][Full Text] [Related]
4. Low rates of osteoporosis treatment after hospitalization for hip fracture in Hawaii.
Nguyen ET; Posas-Mendoza T; Siu AM; Ahn HJ; Choi SY; Lim SY
Osteoporos Int; 2018 Aug; 29(8):1827-1832. PubMed ID: 29744567
[TBL] [Abstract][Full Text] [Related]
5. What is a reasonable rate for specific osteoporosis drug therapy in older fragility fracture patients?
Gosch M; Bail HJ; Grueninger S; Stumpf U; Kammerlander C; Wicklein S
Arch Osteoporos; 2020 Feb; 15(1):20. PubMed ID: 32088765
[TBL] [Abstract][Full Text] [Related]
6. Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis.
Palacios S; Kalouche-Khalil L; Rizzoli R; Zapalowski C; Resch H; Adachi JD; Gallagher JC; Feldman RG; Kendler DL; Wang A; Wagman RB; Adami S
Climacteric; 2015; 18(6):805-12. PubMed ID: 26029985
[TBL] [Abstract][Full Text] [Related]
7. Declining rates of osteoporosis management following fragility fractures in the U.S., 2000 through 2009.
Balasubramanian A; Tosi LL; Lane JM; Dirschl DR; Ho PR; O'Malley CD
J Bone Joint Surg Am; 2014 Apr; 96(7):e52. PubMed ID: 24695929
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
Pedersen AB; Heide-Jørgensen U; Sørensen HT; Prieto-Alhambra D; Ehrenstein V
JAMA Netw Open; 2019 Apr; 2(4):e192416. PubMed ID: 31002319
[TBL] [Abstract][Full Text] [Related]
9. Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fracture.
Ferrari S; Reginster JY; Brandi ML; Kanis JA; Devogelaer JP; Kaufman JM; Féron JM; Kurth A; Rizzoli R
Arch Osteoporos; 2016 Dec; 11(1):37. PubMed ID: 27800591
[TBL] [Abstract][Full Text] [Related]
10. Improvement in the primary and secondary prevention of osteoporosis by a Fracture Liaison Service: feedback from a single French center care pathway.
Vrignaud A; Pelletier S; Dernis E; Moui Y; Haettich B
Arch Osteoporos; 2018 Oct; 13(1):110. PubMed ID: 30324242
[TBL] [Abstract][Full Text] [Related]
11. Fracture prevention service to bridge the osteoporosis care gap.
Ruggiero C; Zampi E; Rinonapoli G; Baroni M; Serra R; Zengarini E; Baglioni G; Duranti G; Ercolani S; Conti F; Caraffa A; Mecocci P; Brandi ML
Clin Interv Aging; 2015; 10():1035-42. PubMed ID: 26150707
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention of osteoporotic fractures: evaluation of the Lille University Hospital's Fracture Liaison Service between January 2016 and January 2018.
Pflimlin A; Gournay A; Delabrière I; Chantelot C; Puisieux F; Cortet B; Paccou J
Osteoporos Int; 2019 Sep; 30(9):1779-1788. PubMed ID: 31190123
[TBL] [Abstract][Full Text] [Related]
13. Inpatient Zoledronic Acid and Integrated Orthopedic and Fracture Liaison Services Improve Osteoporosis Treatment Rates.
Fan W; Machado M; Leder BZ; Beyer L; Garcia EF; Kronenberg HM; Cevallos S; Espinoza J; Finkelstein JS; Bolster MB
J Clin Endocrinol Metab; 2022 Dec; 108(1):191-197. PubMed ID: 36056816
[TBL] [Abstract][Full Text] [Related]
14. Management of osteoporosis in patients hospitalized for hip fractures.
Ip TP; Leung J; Kung AW
Osteoporos Int; 2010 Dec; 21(Suppl 4):S605-14. PubMed ID: 21058000
[TBL] [Abstract][Full Text] [Related]
15. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
[TBL] [Abstract][Full Text] [Related]
16. Low rate of densitometric diagnosis and treatment in patients with severe osteoporosis in Colombia.
Fernández-Ávila DG; Rincón-Riaño DN; Pinzón DF; Gutiérrez Dávila JM
Arch Osteoporos; 2019 Sep; 14(1):95. PubMed ID: 31486920
[TBL] [Abstract][Full Text] [Related]
17. [Primary and Secondary Prevention of Hip Fragility Fracture in Teruel Health Sector, Aragon, Spain].
Gómez Navarro R; González García P; Martín Hernández C; Castro Sauras Á; Valdearcos Enguídanos S
Rev Esp Salud Publica; 2017 Jan; 91():. PubMed ID: 28025971
[TBL] [Abstract][Full Text] [Related]
18. Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.
Shah A; Prieto-Alhambra D; Hawley S; Delmestri A; Lippett J; Cooper C; Judge A; Javaid MK;
Osteoporos Int; 2017 Jan; 28(1):169-178. PubMed ID: 27812809
[TBL] [Abstract][Full Text] [Related]
19. Effects of bone remodeling agents following teriparatide treatment.
Burkard D; Beckett T; Kourtjian E; Messingschlager C; Sipahi R; Padley M; Stubbart J
Osteoporos Int; 2018 Jun; 29(6):1351-1357. PubMed ID: 29541794
[TBL] [Abstract][Full Text] [Related]
20. Use of anti-osteoporosis medication dispensing by patients with hip fracture: could we do better?
Kristensen PK; Ehrenstein V; Shetty N; Pedersen AB
Osteoporos Int; 2019 Sep; 30(9):1817-1825. PubMed ID: 31263921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
